The FDA has proposed to amend its regulation that defines "biological product" to incorporate changes made by the Biologics Price Competition and Innovation Act of 2009 (BPCI Act), and to provide its interpretation of the statutory terms "protein" and "chemically synthesized polypeptide."
The FDA has announced the withdrawal of the proposed rule on "Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products," published in the Federal Register of Nov. 13, 2013.
OSHA reports an increase in recent years in the reporting of cumulative trauma disorders (CTDs) and other work-related disorders due to ergonomic hazards, which are physical conditions that can pose risk of injury to the musculoskeletal system.
All food processors, no matter what they produce or where they are located, should develop, document, implement and maintain a program for traceability and recalls.
The FDA will hold four public meetings to discuss “Standards for the Growing, Harvesting, Packing and Holding of Produce for Human Consumption: Draft Guidance for Industry.”
The USDA's Agricultural Marketing Service (AMS) has amended the Marketing Order that regulates the handling of raisins produced from grapes grown in California.
The FDA has announced the availability of draft guidance entitled “Food Labeling: Serving Sizes of Foods That Can Reasonably Be Consumed At One Eating Occasion, Reference Amounts Customarily Consumed, Serving-Size Related Issues, Dual Column Labeling and Miscellaneous Topics.”
